SARS-CoV-2 IgG

Description: 
The SARS-CoV-2 IgG assay is a chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum.
This test is not UKAS accredited
Clinical details: 
The SARS-CoV-2 IgG assay is used as an aid in the diagnosis of SARS-CoV-2 infection in conjunction with clinical presentation. It is also used to guide appropriate antiviral treatment.
Related condition or disease: 
COVID-19, coronavirus, respiratory virus infection
Synonyms or keywords: 
COVID-19, SARS-CoV-2, Coronavirus
Units: 
Qualitative Test – Detected/Not Detected
Department: 
Infection Sciences Department
Location: 
Blackfriar's Hub
Sample type and Volume required: 
2.5 – 5ml Yellow Top Serum Separation Tube (SST) Clotted Blood (for serum).
Turnaround time: 
1 day. This assay is run 7 days a week. Samples received before 9am can be reported the same day. Contact the GSTT Viapath Virology lab for any urgent requests.
Criteria for acceptance / rejections of sample
Storage and transport: 
Place labelled sample in a sealed sample bag and send to Central Specimen Reception (CSR). Samples should be sent to CSR promptly as the sensitivity of assays depend on sample quality/integrity. Please store samples in a refrigerator if there is a delay in sending samples to CSR.
Contacts:
For clinical advice or interpretation of results, please contact the laboratory in the first instance.
Laboratory: 
Virology Laboratory at Blackfriars Hub

Print as a PDF

Last updated: 18/12/2024